ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment

Immune checkpoint inhibitors (ICIs) have shown promising results in bladder cancer (BC). However, only some patients respond to ICIs. DNA repair defects (DDR) play an important role in the therapeutic response of bladder cancer. Therefore, we aimed to elucidate the association between ICIs in bladde...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Genet
Päätekijät: Yi, Ruibin, Lin, Anqi, Cao, Manming, Xu, Abai, Luo, Peng, Zhang, Jian
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Genetics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7456912/
https://ncbi.nlm.nih.gov/pubmed/32922441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2020.00933
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia